Biodefense Market Size

Biodefense Market Size

Biodefense Market size surpassed USD 15.6 billion in 2021 and is expected to witness an 8.7% CAGR from 2022 to 2028 owing to the government-led several safety measures and stock vaccines to protect the economy from damages caused by bioterrorism attacks in developed countries.

To get key market trends

  Download Free Sample

Bioterrorism refers to the deliberate release of viruses, bacteria, and other hazardous germs with the potential to spread epidemics and cause death. This condition has a negative impact on the economy because it is harmful to human health and depletes human resources. As a result, governments in developed countries undertake a variety of efforts as well as preventative measures in order to withstand these attacks. Vaccines and biothreat detection technologies are frequently stocked by the government to ensure the safety of the population. Government initiatives like this will help to accelerate the biodefense market share.

The COVID-19 pandemic had a favorable influence on the biodefense market. The COVID-19 pandemic demonstrates how catastrophic biological events may result in significant human and economic loss, necessitating a nationwide response from numerous government and nonfederal agencies. There are several reasons to believe that the COVID-19 pandemic is an intentional act of bioterrorism. COVID-19 promises a huge potential for investment and income redistribution, similar to the swine flu epidemic of 2008-2009, when billions were created by major companies across the globe.

Bio-defenses is a combination of various processes and systems put in place by customs agents, bioscience laboratories, and other professionals to prevent the use of dangerous pathogens and toxins. Biodefense uses medical procedures to protect people against bioterrorism. The purposeful release of viruses, bacteria, or other organisms to cause sickness or death is referred to as a bioterrorism.